The Future of Bladder Cancer Therapies: Integrating Hydrogel Scaffolds for Epigenetic Regulator Delivery. [PDF]
John KA +5 more
europepmc +1 more source
Clinical and pharmacovigilance safety evaluation of LUXTURNA<sup>®</sup> (voretigene neparvovec-rzyl). [PDF]
Simoens D, Shravah V, Jones WK, Kaja S.
europepmc +1 more source
Safety and effectiveness of stiripentol in patients with Dravet syndrome: A prospective, 3-year, postmarketing surveillance study. [PDF]
Kitamura Y +6 more
europepmc +1 more source
Postmarketing safety of migraine prophylactic monoclonal antibodies: An EudraVigilance database analysis of eptinezumab, fremanezumab, galcanezumab, and erenumab. [PDF]
Nikitina V +3 more
europepmc +1 more source
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes [PDF]
Cappellini, MD +4 more
core
Safety of the Selective JAK1 Inhibitor Oclacitinib in Dogs. [PDF]
Nederveld SM, Krautmann MJ, Mitchell J.
europepmc +1 more source
Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a review. [PDF]
D'souza J, Nandave M, Blöchlinger R.
europepmc +1 more source
Emerging Isseus in FDA Regulation: Warning Letters, Internet Promotion, and Tobacco [PDF]
Senger, Jeffrey M.
core
WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever- key considerations and research gaps. [PDF]
Ibarz Pavon AB +13 more
europepmc +1 more source
Hyaluronic Acid Hybrid Cooperative Complexes Nearing 10 Years of Use: Update on Safety Assessment Based on Post-Marketing Surveillance Data. [PDF]
Salti G +8 more
europepmc +1 more source

